Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph- B-ALL

Clinical trial NCT04740203 · UNKNOWN

Trial details

NCT number: NCT04740203
Sponsor: Zhejiang University
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-Cell Acute Lymphoblastic Leukemia, Adult

Start date: 2021-01-31
Primary completion: 2024-01-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.